Sustained release L-arginine formulations and methods of manufacture and use

Details for Australian Patent Application No. 2004279298 (hide)

Owner Palmetto Pharmaceuticals, LLC

Inventors Ron, Eyal S.

Agent Cullen & Co

Pub. Number AU-B-2004279298

PCT Pub. Number WO2005/035001

Priority 60/512,035 17.10.03 US; 60/507,312 29.09.03 US; PCT/US03/033931 24.10.03 US

Filing date 28 April 2004

Wipo publication date 21 April 2005

Acceptance publication date 29 January 2009

International Classifications

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035001 Priority application(s): WO2005/035001

15 November 2007 Assignment before Grant

  ENOS Pharmaceuticals, Inc. The application has been assigned to Palmetto Pharmaceuticals, LLC

29 January 2009 Application Accepted

  Published as AU-B-2004279298

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279312-An intramedullary implant for fracture fixation

2004279294-Activated vapor treatment for neutralizing warfare agents